Navigation Links
StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform
Date:5/14/2008

MENLO PARK, Calif., May 14 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing clinical systems for Enabling Regenerative Medicine(TM), announced today that it has been awarded a National Institutes of Health Phase I Small Business Innovation Research (SBIR) Grant entitled "Adult Stem Cell Minimally Invasive Bone Marrow Harvester." The award is to further develop the MarrowMiner(TM) which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for harvesting bone marrow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071030/STEMCORSYSTEMSLOGO)

"We are pleased to have been awarded this grant," commented Vartan Ghazarossian, PhD, President and CEO of StemCor Systems, Inc. "This SBIR award provides further validation of our scientific and clinical approach, to satisfy the unmet need to easily and effectively obtain marrow-derived cells. The grant will be used to broaden our capabilities regarding the harvest of bone marrow, as well as the processing of stem and progenitor cells it contains, for bone marrow transplantation. Additionally," he explained, "the MarrowMiner System has the potential to improve upon a growing number of therapeutic applications in the field of Regenerative Medicine including cardiovascular, neurologic, diabetic and orthopedic disorders."

About the MarrowMiner

The proprietary MarrowMiner System is designed to rapidly and easily harvest stem cell-rich bone marrow in a minimally-invasive manner, in the outpatient setting, and without general anesthesia. This is in contrast to the current practice of bone marrow aspiration through the insertion of a large gauge needle into multiple sites of the iliac crest of the hip, which usually requires general anesthesia, an operating room, and multiple clinical personnel, and results in marrow highly diluted with peripheral blood. Preclinical studies demonstrate that the MarrowMiner can safely harvest large volumes of marrow with significantly higher stem cell activity than is obtained with marrow harvested by means of standard needle aspirates.

About Bone Marrow

Bone marrow is a rich source of both adult stem and progenitor cells. Marrow-derived stem cells have been utilized extensively for over 40 years in the field of bone marrow transplantation, primarily for the treatment of a wide array of cancers and hematologic diseases for which over 60,000 transplants are performed each year. Orthopedic procedures, such as spinal fusions and the treatment of non-union fractures, also commonly utilize the patient's own bone marrow. More recently, marrow-derived cells are showing promise in the treatment of a widening array of diseases and conditions.

About Regenerative Medicine

Regenerative medicine focuses on the ability to repair or regenerate damaged, diseased or aging tissues, and is rapidly emerging as the next frontier in medicine. Regenerative therapies have the potential to provide effective treatment for millions of patients worldwide suffering from a wide array of diseases, including cardiovascular, endocrine (i.e. diabetes), neurologic, and orthopedic diseases. A critical aspect of many regenerative therapies is the ability to utilize the patient's own stem and progenitor cells, requiring the harvest, processing, and delivery of these cells to a target organ.

About StemCor

StemCor Systems is a privately held medical device company located in the San Francisco Bay Area developing enabling technologies for regenerative medicine. The company's initial product is the MarrowMiner, a proprietary, minimally-invasive bone marrow collection system. The technology was invented by Daniel Kraft, MD, and was licensed exclusively from Stanford University. Clinical studies are now underway to evaluate the potential of the MarrowMiner System to obtain sufficient and high quality marrow-derived cells.

Contact: Vartan Ghazarossian, PhD

President and CEO

StemCor Systems, Inc.

650-321-6884

Vartan@StemCorSystems.com


'/>"/>
SOURCE StemCor Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Solei Systems, Inc., Announces That the Company Is Now Publicly Traded
2. Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
3. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
4. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
5. QSV Biologics awarded cGMP manufacturing contract by Pfizer Inc.
6. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
7. Chassapis and team awarded $3 million GK-12 grant from NSF for multiscale research
8. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
9. Genomas Awarded $1.2 Million NIH SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy
10. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
11. Jivan Awarded US Patent #7,340,349 for Splice Array Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):